NINE MASTS CAPITAL Ltd

Position in ABVX — Abivax S.A.

CIK 1569356 CENTRAL, K3

Back to ABVX Full portfolio

Position in ABVX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$132,993

-$702,132 QoQ

Shares Held

998

-86.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#245

of 301 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026

CallValue

$12,393

CallShares

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NINE MASTS CAPITAL Ltd holds $2,069,717 across 4 Biotechnology names. ABVX ranks #4 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	9,400	$1,247,662
2	VERA	Vera Therapeutics, Inc.	9,434	$404,812
3	INBX	Inhibrx Biosciences, Inc.	3,000	$284,250
4	ABVX	Abivax S.A. This page	998	$132,993

All Filings in ABVX

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$132,993	998	-86.7%	Shares	Sole	2026-08-07
2026-06-30	$12,393	93	—	Call	Sole	2026-08-07
2026-03-31	$835,125	7,500	+87.5%	Shares	Sole	2026-05-13
2025-12-31	$539,420	4,000	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.